Safety, Efficacy, and Black Box Warnings: Challenges Associated With Off-Label Treatments of AAD
C. Brendan Montano, MD
Anton P. Porsteinsson, MD
Caregiver Screening Tools for Agitation in Alzheimer’s Disease
Patient-Centric Approaches to Optimizing Outcomes in AAD: Case Review
Proactive Screening: Essential Tools for Diagnosing AAD Quickly
Optimizing Outcomes in AAD in Community PCP and LTC Clinics
Team Approach: Enhancing Collaboration in AAD Management
AAD Treatment Evolution: The Future of Emerging Therapies
Navigating Therapy: Exploring FDA-Approved Treatments for Effective AAD Care
Burden Beyond the Patient: AAD's Impact on Patients and Caregivers
Precision Imaging: MRI's Critical Role in Early MCI AD Diagnosis
Marwan Noel Sabbagh, MD, FAAN, FANA
Beyond Guesswork: Validated Methods for MCI Assessment in Alzheimer's Diagnosis
Professor Sir John Hardy
Early Recognition + Earlier Intervention = Slowing the Progression in Mild Cognitive Impairment / Early Alzheimer’s
Comparative Efficacy: SubQ vs. Intravenous DMTs in Alzheimer's Disease
Therapeutic Insights: Navigating the Use and Challenges of Disease-Modifying Therapies
Future Frontiers: The Future Landscape of Alzheimer's Therapeutics
Loading...
We're glad to see you're enjoying MedEd On The Go… but how about a more personalized experience?
Press cancel to remain on MedEd On The Go. Press the link below or the continue button to keep going.